Mein Warenkorb

Human EGF ELISA Kit

User Reviews
Product Number/Spec
Price
Menge
CEA-C080-96tests
$565.00
ETA of in-stock products:2 business days
Gesamtanzahl Product Amount$ 0

Product Details

  • Product Overview

    Human EGF ELISA Kit is a ready-to-use immunoassay kit, specifically designed to quantitate natural and recombinant human EGF that is present in biological samples, such as human serum, plasma, and cell culture supernatants. Our ELISA Kit provides several benefits:

    1. Standards to calibrate with NIBSC/WHO standards for comparable results.
    2. Fully validation in biologic samples for detection range, sensitivity, inter- and intra-plate CV, recovery, dilution linearity, specificity, and matrix effects to ensure reliable results according to ICH M10 guideline.
    3. High-quality antibody pairs and protein standards, along with rigorous quality control, to guarantee consistent results across different batches.
    4. Simplified and straightforward protocols and ready-to-use reagents to save assay time.

  • Product Specifications

    Assay Type
    Sandwich-ELISA
    Analyte
    EGF
    Format
    96-wells plate breakable into 12 x 8 wells strips
    Reactivity
    Human
    Sensitivity
    <35 pg/mL
    Assay Time
    2 hr 45 min
    Sample volume
    50 μL
    Range
    62.5 pg/mL-8000 pg/mL
    Sample Type
    Cell Culture Supernatants, Plasma, Serum.
    NIBSC Code
    91/530

    Elevate your research experience with our Cytokine/Biomarker Detection Kits, where accuracy, reliability, and ease of use are converging to deliver exceptional results.

  • Application

    The kit is developed for quantitative detection of natural and recombinant human EGF in serum, plasma and cell culture supernatants.

    It is for research use only.

  • Workflow

    EGF Workflow

  • Storage

    Keep the unopened kit stored at 2-8 °C. Avoid using the kit beyond its expiration date. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

  • Materials Provided

    ID
    Components
    Size
    CEA080-C01
    Pre-coated Anti-EGF Antibody Microplate
    1 plate
    CEA080-C02
    Human EGF Standard
    7.5 μg×2
    CEA080-C03
    Biotin-Anti-EGF Antibody Con. Solution
    100 μL
    CEA080-C04
    Biotin-Antibody Dilution Buffer
    8 mL
    CEA080-C05
    Streptavidin-HRP Con. Solution
    500 μL
    CEA080-C06
    Streptavidin-HRP Dilution Buffer
    15 mL
    CEA080-C07
    20×Washing Buffer
    50 mL
    CEA080-C08
    Sample Dilution Buffer
    15 mL×2
    CEA080-C09
    Substrate Solution
    12 mL
    CEA080-C10
    Stop Solution
    6 mL
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Kunden haben auch angesehen

Data Display

  • Typical Data 

    Please refer to DS document for the assay protocol.

     EGF TYPICAL DATA

    For each experiment, a standard curve needs to be set for each microplate, and the specific OD value may vary depending on different laboratories, testers, or equipment. The following example data is for reference only. The sample concentration was calculated based on the results of the standard curve. The minimum detectable concentration of EGF is less than 35 pg/mL.

Validation
  • Intra-Assay Statistics

    Ten replicates of each of three samples containing different EGF concentrations were tested in one assay. Acceptable criteria: CV<10%.

     EGF INTRA-ASSAY STATISTICS
  • Inter-Assay Statistics

    Three samples containing different concentrations of EGF were tested in independent assays. Acceptable criteria: CV<15%.

     EGF INTER-ASSAY STATISTICS
  • Recovery

    Recombinant EGF was spiked into three human serum samples, and then analyzed. The average recovery of EGF for serum samples is 105%.

     EGF RECOVERY

User Reviews
Publish Comment

Frontier Progress

 
Drug Development Progress
  • English Name:

    Epidermal growth factor

  • Category:

  • Listed Drugs Count:

    0 Details

  • Clinical Drugs Count:

    4 Details

  • Highest R&D Stage:

    Phase 2 Clinical

Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Kunden haben auch angesehen
  • Data Display
  • User Reviews
Kontaktieren Sie uns